Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

389 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 64,874,151 shares of 105,632,895 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7,480,651 shares), JANUS HENDERSON GROUP PLC (7,398,598 shares), SANDS CAPITAL MANAGEMENT, LLC (5,566,103 shares), BlackRock Inc. (4,760,217 shares), FMR LLC (4,151,448 shares), Capital Research Global Investors (2,542,191 shares), Avoro Capital Advisors LLC (2,500,000 shares), Bank of New York Mellon Corp (1,957,964 shares), Point72 Asset Management, L.P. (1,846,000 shares), and STATE STREET CORP (1,792,094 shares).
This table shows the top 295 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.